| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |